25.000€
Potential collaboration opportunities with Pfizer
ScaleUps Studio is exclusively designed to unlock strategic collaboration opportunities for mature startups and healthtech providers. As the exclusive gateway to Pfizer’s Center for Digital Innovation, and via CDI to the whole Pfizer organization, it enables established companies to present their value proposition and explore concrete pathways for potential partnership and collaboration
Our dedicated Review Committee, comprising Pfizer experts and industry professionals, will evaluate your entry based on a range of criteria, including among others your company's maturity, the relevance to Pfizer’s business, the product/service scalability and the innovation potential.
By participating, you acknowledge and embrace the Review Committee's final decisions, knowing that each evaluation is tailored to the unique needs and business priorities of the company.
Once selected, you'll gain exclusive access to the ScaleUps Studio—a tailored program of meetings and workshops with global Pfizer executives, co-designed around the specific collaboration opportunities your solution offers.
Each team begins with a 1:1 Preparation Workshop to refine their proposal and identify synergies.
Next, they join an Intro Meeting with the Pfizer CDI team to present their solution and explore alignment within Pfizer’s global network.
The process culminates in a Solution Exploration Session, where teams engage with Pfizer stakeholders in focused discussions to assess fit, uncover synergies, and define next steps
While there is no monetary prize associated with participating in the ScaleUps Studio, the benefits are great. By engaging directly with Pfizer's CDI, it is only through ScaleUps Studio that you'll have the opportunity to explore potential partnerships, co-development prospects, and strategic alliances that can propel your company to new heights.
It's important to note that entering the ScaleUps Studio doesn't automatically lead to legally binding contractual agreements with Pfizer. However, ScaleUps Studio is the unique gateway to present your solution and investigate separate, tailored agreements in the future.
Don't miss this chance to revolutionize your business and make a lasting impact in the pharmaceutical and healthcare industry. Apply now to the ScaleUps Studio and embark on a transformative journey with Pfizer.
Pfizer CDI invites the Greek startup ecosystem to carve the future of healthcare through digital innovation, by proposing their visionary ideas in the 4th iteration of the Start4Health challenge.
Acceleration Lab Key Dates
The program includes three consecutive phases: the Open Call, the Acceleration Phase, and the Final Pitch Day.
Open Call Phase
Pfizer CDI invites the Greek startup ecosystem to carve the future of healthcare through Digital Innovation with their visionary ideas in the fourth iteration of the Start4Health challenge. The Open Call phase will begin on October 10, 2025 and will run until November 9, 2025 (11:59 p.m. EET).
Accelerator
The Top 5 startups will enter the Acceleration Phase for six weeks and will be assisted by Pfizer Mentors and Coaches from the ecosystem.
Final Pitch Day
The Final Pitch Day includes pitches, events, and awards of the Top 2 startups.
The program is designed to attract ambitious startups and founders ready to scale impactful solutions in health innovation.
A judging committee, made up of global and local experts from Pfizer and the broader innovation ecosystem, will evaluate and select the Top 5 startups to join the Acceleration Phase.
During this phase, each team will work closely with a dedicated mentor from Pfizer’s global network, and engage in tailored coaching and expert-led sessions to refine their product, strengthen their business model, sharpen their value proposition and enhance their pitching skills.
On the Final Pitch Day, the judging committee will select two winning teams with the most compelling pitches, who will receive significant cash prizes. Beyond the awards, any participating startups with strong and compelling business cases will have the opportunity to explore a potential collaboration with Pfizer CDI.
10.000€
Potential collaboration opportunities with Pfizer